Oral edaravone ameliorates myocardial fibrosis in type 2 diabetic rats by TGF-beta1/Smad signaling pathway. Zhang XY, Xu YX, Xue SQ, Zeng YQ, et al. J Diabetes Complications 2025;39:108976.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhang XY, Xu YX, Xue SQ, Zeng YQ, et al. Oral edaravone ameliorates myocardial fibrosis in type 2 diabetic rats by TGF-beta1/Smad signaling pathway. J Diabetes Complications 2025;39:108976.
PMID: 39985871